North America Prostate Cancer Diagnostics Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Medical Devices North America Prostate Cancer Diagnostics Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Prostate Cancer Diagnostics Market Analysis

  • Medical Devices
  • Published Report
  • Mar 2021
  • North America
  • 350 Pages
  • No of Tables: 94
  • No of Figures: 55
Buy Now Buy Now

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. Epidemiology
  6. COMPARATIVE ANALYSIS WITH PARENT MARKET
  7. REGULATORY FRAMEWORK: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN THE U.S.
  8. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  9. IMPACT OF COVID-19 ON NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    6. CONCLUSION
  10. North America PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  11. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  12. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  13. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  14. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  15. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  16. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  17. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  18. NORTH AMERICA prostate cancer diagnostics market, BY Country
    1. u.s.
    2. canada
    3. mexico
  19. NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
    1. company share analysis: north america
  20. SWOT
  21. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. product Portfoli0
      4. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. OPko HEALTH INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. ACCUQUIK TEST KITS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. Diasorin s.p.a
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLI0
      4. RECENT DEVELOPMENTS
    10. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    12. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. MDXHEALTHCARE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. Metamark genetics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI0
      3. RECENT DEVELOPMENTS
    16. Myraid genetics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Prostatype Genomics
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. TECO DIAGNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  22. questionnaire
  23. related reports

List of Table

TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988

TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER

TABLE 3 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (USD million)

TABLE 4 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (UNits)

TABLE 5 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 6 NORTH AMERICA preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 7 NORTH AMERICA Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 8 NORTH AMERICA imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 9 NORTH AMERICA Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 10 NORTH AMERICA biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 11 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By type, 2019-2028 (USD million)

TABLE 12 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By age group 2019-2028 (USD million)

TABLE 13 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By Stage, 2019-2028 (USD million)

TABLE 14 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By Sample Type, 2019-2028 (USD million)

TABLE 15 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD million)

TABLE 16 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD million)

TABLE 17 North America PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD million)

TABLE 18 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD million)

TABLE 19 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 20 U.S. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 21 U.S. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 22 U.S. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 23 U.S. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 24 U.S. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 25 U.S. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 26 U.S. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD million)

TABLE 27 U.S. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD million)

TABLE 28 U.S. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD million)

TABLE 29 U.S. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD million)

TABLE 30 U.S. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD million)

TABLE 31 U.S. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD million)

TABLE 32 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD million)

TABLE 33 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 34 CANADA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 35 CANADA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 36 CANADA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 37 CANADA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 38 CANADA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 39 CANADA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 40 CANADA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD million)

TABLE 41 CANADA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD million)

TABLE 42 CANADA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD million)

TABLE 43 CANADA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD million)

TABLE 44 CANADA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD million)

TABLE 45 CANADA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD million)

TABLE 46 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD million)

TABLE 47 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 48 MEXICO Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 49 MEXICO Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 50 MEXICO Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 51 MEXICO Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 52 MEXICO Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 53 MEXICO Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD million)

TABLE 54 MEXICO Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD million)

TABLE 55 MEXICO Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD million)

TABLE 56 MEXICO Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD million)

TABLE 57 MEXICO Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD million)

TABLE 58 MEXICO Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD million)

TABLE 59 MEXICO Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD million)

List of Figure

FIGURE 1 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation

FIGURE 3 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID

FIGURE 10 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE North America prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the North America prostate cancer diagnostics market in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 15 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2020

FIGURE 16 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2021-2028 (USD MILLION)

FIGURE 17 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, CAGR (2021-2028)

FIGURE 18 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE

FIGURE 19 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, 2020

FIGURE 20 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE 2021-2028 (USD MILLION)

FIGURE 21 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 22 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 23 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2020

FIGURE 24 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2021-2028 (USD MILLION)

FIGURE 25 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, CAGR (2021-2028)

FIGURE 26 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: By type, LIFELINE CURVE

FIGURE 27 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, 2020

FIGURE 28 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group , 2021-2028 (USD MILLION)

FIGURE 29 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, CAGR (2021-2028)

FIGURE 30 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, LIFELINE CURVE

FIGURE 31 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2020

FIGURE 32 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2021-2028 (USD MILLION)

FIGURE 33 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, CAGR (2021-2028)

FIGURE 34 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, LIFELINE CURVE

FIGURE 35 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2020

FIGURE 36 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2021-2028 (USD MILLION)

FIGURE 37 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, CAGR (2021-2028)

FIGURE 38 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, LIFELINE CURVE

FIGURE 39 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2020

FIGURE 40 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2021-2028 (USD MILLION)

FIGURE 41 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, CAGR (2021-2028)

FIGURE 42 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, LIFELINE CURVE

FIGURE 43 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2020

FIGURE 44 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 45 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 46 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution, LIFELINE CURVE

FIGURE 47 North America Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 48 North America Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 49 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 51 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 52 north america Prostate cancer diagnostics market: company share 2020 (%)

Browse Related Pages

Banner